MFA Wealth Advisors’s AbbVie ABBV Stock Holding History

MFA Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$210K	Buy	+833	New	+$179K	0.04%	96
2025 Q2	–	Sell	-995	Closed	-$208K	–	89
2025 Q1	$208K	Buy	+995	New	+$193K	0.05%	87
2024 Q4	–	Sell	-880	Closed	-$174K	–	78
2024 Q3	$174K	Sell	880 -150	-15%	-$28K	0.04%	102
2024 Q2	$177K	Buy	+1,030	New	+$171K	0.04%	106
2020 Q3	–	Sell	-469	Closed	-$46K	–	40
2020 Q2	$46K	Buy	+469	New	+$41.3K	0.03%	76
2018 Q3	–	Sell	-11,592	Closed	-$1.1M	–	53
2018 Q2	$1.1M	Buy	11,592 +39	+0.3%	+$3.81K	0.72%	27
2018 Q1	$1.16M	Buy	11,553 +66	+0.6%	+$7.25K	0.88%	23
2017 Q4	$1.34M	Buy	+11,487	New	+$1.08M	0.91%	24

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

MFA Wealth Advisors's ABBV Position: Q2 2026 in Review

MFA Wealth Advisors opened a new position in AbbVie (ABBV) in Q2 2026: 833 shares worth $210K. The stake represents 0.04% of the portfolio and ranks #96 among its holdings. This is a return to the name: MFA Wealth Advisors previously reported a position in ABBV as recently as Q1 2025.

MFA Wealth Advisors first reported a position in ABBV in Q4 2017 and has held it in 8 quarters since. The position peaked at $1.34M in Q4 2017. 2,011 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

MFA Wealth Advisors held 833 shares of AbbVie worth $210K as of Q2 2026.
AbbVie was a new MFA Wealth Advisors position in Q2 2026.
AbbVie made up 0.04% of MFA Wealth Advisors's portfolio in Q2 2026, its #96 holding.
MFA Wealth Advisors first reported a position in AbbVie in Q4 2017 and has held it in 8 quarters since.
MFA Wealth Advisors's AbbVie position peaked at $1.34M in Q4 2017.
2,011 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on MFA Wealth Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.